Is OGN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for OGN. It does not provide personalized investment advice.

OGN (Organon & Co.) Stock Analysis - Financials

Organon & Co. (OGN) is a publicly traded Healthcare sector company. As of September 14, 2026, OGN trades at $13.55 with a market cap of $3.58B and a P/E ratio of 17.26. OGN moved -0.67% today. Year to date, OGN is +91.30%; over the trailing twelve months it is +27.95%. Its 52-week range spans $5.69 to $17.23. Rallies surfaces OGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are OGN's key financials?

OGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OGN recently traded at $13.55. Market cap is $3.58B. P/E ratio is 17.26. Revenue is $6.13B.

OGN Key Metrics

Key financial metrics for OGN
Metric	Value
Price	$13.55
Market Cap	$3.58B
P/E Ratio	17.26
EPS	$0.79
Dividend Yield	0.02%
52-Week High	$17.23
52-Week Low	$5.69
Volume	172
Avg Volume	0
Revenue (TTM)	$6.13B
Net Income	$209.00M
Gross Margin	52.69%

OGN Analyst Consensus

OGN analyst coverage data. Average price target: $0.00.

Common questions about OGN

What are OGN's key financials?: OGN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OGN recently traded at $13.55. Market cap is $3.58B. P/E ratio is 17.26. Revenue is $6.13B.
Is OGN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for OGN. It does not provide personalized investment advice.